Below are the most recent publications written about "Plaque, Amyloid" by people in Profiles.
-
Sekiya M, Sakakibara Y, Hirota Y, Ito N, Chikamatsu S, Takei K, Nishijima R, Iijima KM. Decreased plasma nicotinamide and altered NAD+ metabolism in glial cells surrounding A? plaques in a mouse model of Alzheimer's disease. Neurobiol Dis. 2024 11; 202:106694.
-
Pilotte J, Huang AS, Khoury S, Zhang X, Tafreshi A, Vanderklish P, Sarraf ST, Pulido JS, Milman T. Detection of TTR Amyloid in the Conjunctiva Using a Novel Fluorescent Ocular Tracer. Transl Vis Sci Technol. 2024 02 01; 13(2):11.
-
Dalakas MC. Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits. Expert Rev Clin Immunol. 2022 04; 18(4):413-423.
-
Sundar S, Battistoni C, McNulty R, Morales F, Gorky J, Foley H, Dhurjati P. An agent-based model to investigate microbial initiation of Alzheimer's via the olfactory system. Theor Biol Med Model. 2020 04 15; 17(1):5.
-
Jutkowitz E, Van Houtven CH, Plassman BL, Mor V. Willingness to Undergo a Risky Treatment to Improve Cognition Among Persons With Cognitive Impairment Who Received an Amyloid PET Scan. Alzheimer Dis Assoc Disord. 2020 Jan-Mar; 34(1):1-9.
-
Stern RA, Adler CH, Chen K, Navitsky M, Luo J, Dodick DW, Alosco ML, Tripodis Y, Goradia DD, Martin B, Mastroeni D, Fritts NG, Jarnagin J, Devous MD, Mintun MA, Pontecorvo MJ, Shenton ME, Reiman EM. Tau Positron-Emission Tomography in Former National Football League Players. N Engl J Med. 2019 05 02; 380(18):1716-1725.
-
Sakakibara Y, Sekiya M, Saito T, Saido TC, Iijima KM. Amyloid-? plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease. BMC Neurosci. 2019 Mar 20; 20(1):13.
-
Sandelius ?, Portelius E, K?ll?n ?, Zetterberg H, Rot U, Olsson B, Toledo JB, Shaw LM, Lee VMY, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk DA, McCluskey L, Elman L, Kostanjevecki V, Vandijck M, McBride J, Trojanowski JQ, Blennow K. Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology. Alzheimers Dement. 2019 01; 15(1):55-64.
-
Gochoco A, Schilling LM, Sahu J. Violaceous Pink Axillary and Intertriginous Patches: Answer. Am J Dermatopathol. 2018 02; 40(2):148-149.
-
Afanador L, Roltsch EA, Holcomb L, Campbell KS, Keeling DA, Zhang Y, Zimmer DB. The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer's disease mouse model. Cell Calcium. 2014 Aug; 56(2):68-80.